Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2008-05-06 04:48 | 2008-05-01 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | Officer | BUY | $44.35 | 328 | $14,548 | 36,422 |
| 2008-05-06 04:47 | 2008-05-01 | HAE | HAEMONETICS CORP | SWENSON STEPHEN | Officer | BUY | $44.35 | 238 | $10,556 | 3,024 |
| 2008-05-06 04:49 | 2008-05-01 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | BUY | $44.35 | 138 | $6,121 | 3,531 |
| 2008-05-05 19:36 | 2008-05-05 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | SELL | $41.05 | 5,000 | $205,255 | 809,062 |
| 2008-05-05 19:16 | 2008-05-05 | ARAY | Accuray Incorporated | Hampton Wade | Officer | BUY | $8.56 | 9,000 | $77,039 | 9,000 |
| 2008-05-05 22:38 | 2008-05-01 | BDX | BECTON DICKINSON & CO | KOZY WILLIAM A | Officer | OPT+S | $89.57 | 30,167 | $2,701,931 | 82,549 |
| 2008-05-05 17:23 | 2008-02-28 | WST | WEST PHARMACEUTICAL SERVICES INC | ELLERS STEVEN A | Officer | SELL | $43.60 | 10,000 | $436,010 | 114,914 |
| 2008-05-02 17:18 | 2008-05-01 | PODD | INSULET CORP | Diehl R Anthony | Officer | OPT+S | $18.25 | 1,500 | $27,375 | 11,821 |
| 2008-04-26 01:20 | 2008-04-24 | ICUI | ICU MEDICAL INC/DE | SAUCEDO JOSEPH R | Director | BUY | $23.69 | 425 | $10,068 | 765 |
| 2008-04-24 02:45 | 2008-04-21 | HAE | HAEMONETICS CORP | Pare Anthony | OPT+S | $55.98 | 500 | $27,990 | 2,292 | |
| 2008-04-21 22:45 | 2008-04-18 | RVP | RETRACTABLE TECHNOLOGIES INC | KUHLMAN RUSSELL B | Officer | BUY | $1.50 | 1,000 | $1,500 | 1,000 |
| 2008-04-21 20:33 | 2008-04-18 | STEM | Microbot Medical Inc. | WEISSMAN IRVING | Director | SELL | $1.39 | 80,000 | $111,016 | 894,062 |
| 2008-04-18 14:57 | 2008-04-16 | ANGO | Angiodynamics Inc. | HOBBS EAMONN P | Director, Officer | BUY | $12.97 | 2,715 | $35,206 | 86,226 |
| 2008-04-16 01:41 | 2008-04-15 | CRY | Artivion Inc. | SEERY GERALD B | Officer | OPT+S | $10.50 | 5,500 | $57,740 | 19,335 |
| 2008-04-10 23:44 | 2005-10-28 | MELA | STRATA Skin Sciences, Inc. | Lufkin Dan W | Director | BUY | $0.00 | 0 | $0 | 5,000 |
| 2008-04-08 01:00 | 2008-04-07 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | SELL | $45.24 | 5,000 | $226,199 | 814,062 |
| 2008-04-04 00:00 | 2008-04-03 | GTF | Nuo Therapeutics, Inc. | MOHAN KSHITIJ | Director, Officer | BUY | $0.91 | 10,000 | $9,136 | 20,000 |
| 2008-04-03 23:25 | 2008-04-03 | GTF | Nuo Therapeutics, Inc. | Maslan Andrew Scott | Officer | BUY | $0.75 | 5,000 | $3,744 | 9,000 |
| 2008-04-03 22:10 | 2008-04-03 | GTF | Nuo Therapeutics, Inc. | ROSENDALE MARTIN P | Officer | BUY | $0.85 | 10,000 | $8,500 | 10,000 |
| 2008-04-01 23:16 | 2008-04-01 | PODD | INSULET CORP | Diehl R Anthony | Officer | OPT+S | $14.21 | 1,500 | $21,315 | 11,821 |
| 2008-03-25 16:38 | 2008-02-01 | INHI-OB | InfuSystem Holdings, Inc | McDevitt Sean | Director | BUY | $4.23 | 1,000 | $4,225 | 1,000 |
| 2008-03-19 18:06 | 2008-03-17 | UFPT | UFP TECHNOLOGIES INC | BAILLY RICHARD L | Director | SELL | $6.58 | 1,392 | $9,155 | 206,447 |
| 2008-03-19 23:19 | 2008-03-19 | ANIK | Anika Therapeutics Inc. | QUINLAN KEVIN W | Officer | BUY | $8.29 | 2,000 | $16,578 | 3,000 |
| 2008-03-19 23:51 | 2008-03-18 | PODD | INSULET CORP | Schmid Kevin | Officer | SELL | $12.63 | 6,500 | $82,118 | 17,500 |
| 2008-03-19 20:30 | 2008-03-17 | TFX | TELEFLEX INC | BARRON PATRICIA C | Director | OPT+S | $48.74 | 6,291 | $306,633 | 2,958 |
| 2008-03-19 01:07 | 2008-03-14 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | BUY | $4.92 | 30,000 | $147,732 | 30,000 |
| 2008-03-18 18:20 | 2008-03-14 | CRY | Artivion Inc. | McCall Ronald D | Director | OPT+S | $9.02 | 900 | $8,118 | 138,526 |
| 2008-03-17 21:51 | 2008-03-14 | ATEC | Alphatec Holdings, Inc. | Garner Ebun | Officer | BUY | $5.08 | 3,000 | $15,248 | 33,357 |
| 2008-03-17 20:16 | 2008-03-13 | ATRC | AtriCure, Inc. | Wrubel Lee R | Director | SELL | $11.09 | 34,067 | $377,806 | 382,060 |
| 2008-03-18 01:24 | 2008-03-14 | ANIK | Anika Therapeutics Inc. | SHERWOOD CHARLES H | Director, Officer | SELL | $9.03 | 3,100 | $28,000 | 142,500 |
| 2008-03-18 01:20 | 2008-03-14 | ANIK | Anika Therapeutics Inc. | SHERWOOD CHARLES H | Director, Officer | SELL | $8.69 | 8,986 | $78,063 | 145,600 |
| 2008-03-18 01:02 | 2008-03-13 | ANIK | Anika Therapeutics Inc. | SHERWOOD CHARLES H | Director, Officer | OPT+S | $9.11 | 17,914 | $163,157 | 154,586 |
| 2008-03-17 23:13 | 2008-03-12 | TFX | TELEFLEX INC | LUBSEN SIGISMUNDUS W W | Director | BUY | $51.13 | 530 | $27,099 | 2,741 |
| 2008-03-18 00:47 | 2008-03-12 | HAE | HAEMONETICS CORP | SWENSON STEPHEN | Officer | OPT+S | $58.72 | 623 | $36,580 | 2,786 |
| 2008-03-18 00:18 | 2008-03-14 | DXCM | DEXCOM INC | LUCAS DONALD L | Director | BUY | $4.92 | 35,000 | $172,151 | 354,916 |
| 2008-03-17 19:09 | 2008-03-14 | DXCM | DEXCOM INC | NELSON GLEN D | Director | BUY | $4.87 | 100,000 | $487,250 | 170,654 |
| 2008-03-14 23:18 | 2008-03-12 | UFPT | UFP TECHNOLOGIES INC | BAILLY RICHARD L | Director | OPT+S | $6.75 | 15,643 | $105,593 | 207,839 |
| 2008-03-14 22:34 | 2008-03-13 | UFPT | UFP TECHNOLOGIES INC | GESTAL KENNETH L | Director | OPT+S | $6.62 | 4,500 | $29,805 | 40,200 |
| 2008-03-15 00:04 | 2008-03-14 | DXCM | DEXCOM INC | SKYLER JAY S | Director | BUY | $4.96 | 20,000 | $99,292 | 120,129 |
| 2008-03-15 00:03 | 2008-03-14 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | BUY | $4.87 | 2,000 | $9,740 | 8,201 |
| 2008-03-14 22:20 | 2008-03-13 | CRY | Artivion Inc. | RONALD C ELKINS | Director | SELL | $8.76 | 3,705 | $32,442 | 68,750 |
| 2008-03-14 00:17 | 2008-03-11 | UFPT | UFP TECHNOLOGIES INC | BAILLY RICHARD L | Director | OPT+S | $7.00 | 465 | $3,255 | 216,447 |
| 2008-03-14 03:07 | 2008-03-07 | OCLS | Sonoma Pharmaceuticals, Inc. | Alimi Hojabr | Director, Officer | SELL | $5.36 | 15,000 | $80,400 | 981,250 |
| 2008-03-14 03:55 | 2008-03-12 | ANIK | Anika Therapeutics Inc. | SHERWOOD CHARLES H | Director, Officer | SELL | $9.40 | 6,300 | $59,197 | 127,500 |
| 2008-03-14 03:55 | 2008-03-11 | ANIK | Anika Therapeutics Inc. | SHERWOOD CHARLES H | Director, Officer | OPT+S | $9.47 | 13,609 | $128,820 | 133,800 |
| 2008-03-14 03:55 | 2008-03-11 | ANIK | Anika Therapeutics Inc. | SHERWOOD CHARLES H | Director, Officer | OPT+S | $9.64 | 10,091 | $97,284 | 132,409 |
| 2008-03-14 01:39 | 2008-03-12 | CRY | Artivion Inc. | McCall Ronald D | Director | OPT+S | $8.80 | 15,000 | $132,000 | 138,526 |
| 2008-03-12 22:40 | 2008-03-10 | ANIK | Anika Therapeutics Inc. | Mrachek William | Officer | BUY | $9.16 | 500 | $4,580 | 1,600 |
| 2008-03-13 00:23 | 2008-03-12 | ECI | ENCISION INC | SERINO JOHN R | Officer | BUY | $2.00 | 10,000 | $19,955 | 20,000 |
| 2008-03-12 22:41 | 2008-03-10 | ANIK | Anika Therapeutics Inc. | QUINLAN KEVIN W | Officer | BUY | $9.88 | 1,000 | $9,875 | 1,000 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.